drugset / Trial / NCT06026917

Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)

NCT06026917

NaSingle-groupOpen-labelTreatment

Summary

This study was a single-arm, open-label clinical study to assess dopamine transporter occupancy in the brain of patients with depression using 11C-CFT positron emission tomography (PET).

Timeline

Start
2023-09-25
Primary completion
2024-01-31
Completion
2024-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Toludesvenlafaxine Small molecule 80 mg
Subject Toludesvenlafaxine Small molecule 160 mg